Smithville, MO, United States of America

Christopher Dillard Cline

USPTO Granted Patents = 6 

Average Co-Inventor Count = 4.5

ph-index = 3

Forward Citations = 23(Granted Patents)


Company Filing History:


Years Active: 2015-2024

Loading Chart...
6 patents (USPTO):Explore Patents

Title: **Inventor Spotlight: Christopher Dillard Cline**

Introduction

Christopher Dillard Cline, an innovative inventor based in Smithville, Missouri, has made notable contributions to the field of clinical messaging. With a total of six patents to his name, Cline is recognized for his expertise in developing systems that enhance communication within clinical settings.

Latest Patents

Among his latest innovations, Cline has focused on a robust messaging protocol designed to ensure security and scalability in clinical messaging. This protocol allows for the federation of messages across various messaging domains, enabling direct targeting of addresses or utilizing role-based endpoints that can resolve to multiple target addresses. Additionally, the protocol is versatile, permitting the inclusion of content beyond just text, thus enhancing the richness of communication in medical environments.

Career Highlights

Cline has showcased his inventive spirit during his tenure at Cerner Innovation, Inc., a leading company in health technology. His work there has played a crucial role in developing groundbreaking solutions for healthcare communication.

Collaborations

Throughout his career, Cline has collaborated with several skilled colleagues, including Joel Robert Norton and Scott Gordon Siebers. Their combined efforts have undoubtedly contributed to the successful execution of innovative projects and the advancement of clinical messaging protocols.

Conclusion

Christopher Dillard Cline stands out in the world of invention, particularly in the realm of clinical communications. Through his patents and collaborative work, he continues to pave the way for innovations that enhance security and efficiency in healthcare messaging systems.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…